Marco Bandini

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2019 · 320 citations

Medicine, Oncology, Urology +12

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer

Giorgio Gandaglia, Nicola Fossati, Emanuele Zaffuto et al. · European Urology · 2017 · 238 citations

Medicine, Surgery, Urology +17

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2020 · 178 citations

Medicine, Immunology, Oncology +17

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study

Andrea Necchi, Marco Bandini, Giuseppina Calareso et al. · European Urology · 2019 · 113 citations

Medicine, Oncology, Radiology +15

Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Giuseppe Basile, Marco Bandini, Ewan A. Gibb et al. · Clinical Cancer Research · 2022 · 111 citations · Full text

Medicine, Oncology, Urology +17